openPR Logo
Press release

Cyclosporine Drugs Market Share, Trends, Growth, Future Prospects, Forecast 2020 to 2026

06-24-2020 04:18 PM CET | Health & Medicine

Press release from: Orion Market Research

Cyclosporine Drugs Market

Cyclosporine Drugs Market

The global cyclosporine drugs market is anticipated to showcase considerable growth during the forecast period (2020-2026). The new product launches with rising FDA approvals are a factor contributing to the growth of the global cyclosporine drugs market. Cyclosporine drug is an immunosuppressant class of drugs that is extracted from Tolypocladium fungus which prevents side effects on the immune system such as encephalomyelitis, graft diseases, allograft rejection, delayed hypersensitivity and experimental allergy. In addition, the cyclosporine drug is used in the treatment of a broad spectrum of diseases such as dry eye syndrome, rheumatoid arthritis, and psoriasis. Neoral and Sandimmune are the available drug formulations for the oral route, and Restasis is used for ocular delivery of cyclosporine.

Request a Free Sample of our Report on Cyclosporine Drugs Market: https://www.omrglobal.com/request-sample/cyclosporine-drugs-market

AbbVie Inc., Allergan PLC, Apotex Inc., Eon Labs, Mayne Pharma Group Ltd. McKesson Medical-Surgical Inc., Novartis Inc., Santen Inc., Sun Pharmaceuticals, Teva Pharmaceuticals, and so on are the key players operating in the global cyclosporine drugs market. These players are actively involved in adopting different growth strategies such as mergers and acquisitions, partnerships, collaboration, and strategic agreements among others to remain competitive in the market place. New product launches and investment in the R&D is the key strategy adopted by the players of the global cyclosporine drugs market to sustain their marketplace.

For instance, in March 2019, Breath Therapeutics Inc. had announced the launch of a Ph3 trial for the inhaled liposomal cyclosporine A therapy. In August 2018, Sun Pharmaceutical Industries Ltd. had received US FDA approval for CEQUA (cyclosporine ophthalmic solution) 0.09%. CEQUA is an aqueous solution used to increase tear production in patients suffering from keratoconjunctivitis sicca (dry eye). CEQUA provides the highest FDA-approved concentration of cyclosporine A (CsA) and is based on nanomicellar technology. The innovative nanomicellar formulation used in CEQUA allows the CsA molecule to overcome the solubility challenges involved in the treatment of the dry eyes by penetrating the eye’s aqueous layer and preventing the release of the active lipophilic molecule before the actual penetration.

In May 2018, Teva Canada Ltd, a subsidiary of Teva Pharmaceutical Industries Ltd., had launched Teva-Cyclosporine ophthalmic emulsion, 0.05% w/v, a Health Canada approved twice-daily eye drop solution and the first generic version of Restasis (cyclosporine) in Canada. Cyclosporine ophthalmic emulsion is produced for the treatment of moderate to moderately severe aqueous deficient dry eye syndrome having ocular staining, reduction in tear production, and fluctuating visual symptoms.

A Full Report of Cyclosporine Drugs Market is Available at https://www.omrglobal.com/industry-reports/cyclosporine-drugs-market

Cyclosporine Drugs Market Segmentation

By Indication
• Rheumatoid Arthritis
• Psoriasis
• Transplant Rejection Prophylaxis
• Dry Eye
• Autoimmune Myasthenia Gravis
• Other

By Route of Administration
• Oral
• Parenteral

Cyclosporine Drugs market – Segment by Region

North America
• The US
• Canada

Europe
• Germany
• UK
• France
• Spain
• Italy
• Rest of Europe

Asia-Pacific
• China
• Japan
• India
• Rest of Asia-Pacific

Rest of the World
• Latin America
• Middle East & Africa

Company Profiles
• AbbVie Inc.
• Allergan PLC
• Apotex, Inc.
• Mayne Pharma Group Ltd.
• Mckesson Medical Surgical Inc.
• Novartis AG
• Otsuka Pharmaceutical Co. Ltd.
• Regenerx Biopharmaceuticals, Inc.
• Santen Pharmaceuticals Co. Ltd.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/cyclosporine-drugs-market

For More Information, Visit https://www.omrglobal.com/

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404

About us:
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cyclosporine Drugs Market Share, Trends, Growth, Future Prospects, Forecast 2020 to 2026 here

News-ID: 2079928 • Views:

More Releases from Orion Market Research

Environment Conservation and Wildlife Organization Market Rising Demand and Growth Forecast Through 2033
Environment Conservation and Wildlife Organization Market Rising Demand and Grow …
In 2023, the global market for environment, conservation, and wildlife organizations was approximately USD 26.2 billion, and by 2033, it is projected to reach around USD 41.5 billion, reflecting a compound annual growth rate (CAGR) of approximately 5.0% from 2024 to 2033. Environment Conservation and Wildlife Organization Market Overview The environment, conservation, and wildlife organizations market is experiencing steady growth, driven by increasing public awareness of environmental issues and the need for
Wooden Furniture Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
Wooden Furniture Market Size Analysis, Competitive Insights, Leading Players and …
In 2023, the global wooden furniture market was valued at approximately USD 235.3 billion, and by 2033, it is projected to reach around USD 327.7 billion, reflecting a compound annual growth rate (CAGR) of approximately 3.4% from 2024 to 2033. Wooden Furniture Market Overview The global wooden furniture market is experiencing steady growth, driven by increasing consumer demand for sustainable and aesthetically pleasing home furnishings. Factors such as rising disposable incomes, urbanization,
Warehouse Management Systems Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
Warehouse Management Systems Market Size Analysis, Competitive Insights, Leading …
In 2023, the global Warehouse Management Systems (WMS) market was approximately USD 3.2 billion, and by 2033, it is expected to reach around USD 9.4 billion, reflecting a compound annual growth rate (CAGR) of approximately 11.4% from 2024 to 2033. Warehouse Management Systems Market Overview The Warehouse Management Systems (WMS) market is rapidly growing as businesses increasingly seek to optimize their supply chain and inventory management processes. WMS solutions help improve operational
Space Technology Market Rising Demand and Growth Forecast Through 2033
Space Technology Market Rising Demand and Growth Forecast Through 2033
The global space technology market was valued at approximately USD 443.20 billion in 2023, and is projected to grow to about USD 916.85 billion by 2033, representing a compound annual growth rate (CAGR) of roughly 7.54% during the period from 2024 to 2033. Space Technology Market Overview The space technology market is experiencing strong expansion, driven by a surge in satellite innovation, advances in launch systems, and a growing wave of commercial

All 5 Releases


More Releases for Cyclosporine

Cyclosporine Market Deep Research Report Highlights Industry Outlook - Novartis, …
Cyclosporine Market Snapshot The Cyclosporine Market is projected to reach USD 4.5 billion by 2032, growing at a CAGR of 5.9% from 2025 to 2032. Coherent Market Insights proudly presents its latest Cyclosporine Market Research Report, delivering a detailed examination of the U.S. Cyclosporine Market outlook from 2025 to 2032. This comprehensive analysis provides strategic forecasts at both national and regional levels, addressing evolving supply networks, payer-provider collaboration, and competitive strategies. As
Cyclosporine Market Accelerating Growth with Future Market Size Strategies and T …
In 2024, the global Cyclosporine market is estimated to be valued at approximately USD 2.21 billion, and it is anticipated to reach around USD 3.66 billion by 2033, growing at a compound annual growth rate (CAGR) of 5.5% from 2025 to 2033. Cyclosporine Market Overview The Cyclosporine market is witnessing significant growth, driven by the increasing demand for low-calorie and sugar-free products across various industries. Cyclosporine, a sugar alcohol derived from maltose,
Cyclosporine Market Set to Witness Significant Growth by 2024-2031
The Latest research report on the Cyclosporine Market 2024 provides a comprehensive analysis of the current market landscape, with forecasts extending to 2031. This study combines qualitative and quantitative insights to highlight significant market developments, challenges, competitive dynamics, and potential opportunities and trends shaping the Cyclosporine Market. The report covers market size, recent trends, growth projections, market share, and development status. Additionally, it examines government policies, market dynamics, cost structures,
Cyclosporine Market in the Post-Pandemic Era: Adapting to Change
Allied Market Research added new research on Opportunity Analysis and Industry Forecast,2023-2032. The "Cyclosporine Market" explores comprehensive study on various segments like size, share, development, innovation, sales and overall growth of major players. The research is based on primary and secondary data sources and it consists of both qualitative and quantitative detailing. 𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐑𝐞𝐩𝐨𝐫𝐭: https://www.alliedmarketresearch.com/request-toc-and-sample/3824 𝐖𝐡𝐢𝐜𝐡 𝐦𝐚𝐫𝐤𝐞𝐭 𝐩𝐞𝐫𝐬𝐩𝐞𝐜𝐭𝐢𝐯𝐞𝐬 𝐚𝐫𝐞 𝐞𝐧𝐥𝐢𝐠𝐡𝐭𝐞𝐧𝐞𝐝 𝐢𝐧 𝐭𝐡𝐞 𝐂𝐲𝐜𝐥𝐨𝐬𝐩𝐨𝐫𝐢𝐧𝐞 𝐌𝐚𝐫𝐤𝐞𝐭 𝐫𝐞𝐩𝐨𝐫𝐭? Cyclosporine
Cyclosporine API Market Size, Share By Development, Trend, Key Manufacturers 202 …
Los Angeles, United States,- The research study presented here is a brilliant compilation of different types of analysis of critical aspects of the global Cyclosporine API market. It sheds light on how the global Cyclosporine API market is expected to grow during the course of the forecast period. With SWOT analysis and Porter's Five Forces analysis, it gives a deep explanation of the strengths and weaknesses of the global Cyclosporine API
Cyclosporine Market Growth, Size, Share, Industry Report and Forecast 2021-2027
The global cyclosporine market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Cyclosporine works by suppressing the immune system's responses further preventing the immune system from attacking healthy tissues. The major factor attributed to the market growth includes the rising prevalence of target diseases that include inflammatory and autoimmune diseases, all over the globe. According to the World Psoriasis Day consortium, around 25 million people